Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Invested Capital (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Return on Invested Capital for 15 consecutive years, with 0.03% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital fell 6.0% to 0.03% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.03%, a 6.0% decrease, with the full-year FY2024 number at 0.07%, down 5.0% from a year prior.
  • Return on Invested Capital was 0.03% for Q3 2025 at Usana Health Sciences, down from 0.06% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.52% in Q1 2022 to a low of 0.03% in Q3 2025.
  • A 5-year average of 0.17% and a median of 0.09% in 2024 define the central range for Return on Invested Capital.
  • Biggest YoY gain for Return on Invested Capital was 22bps in 2022; the steepest drop was -44bps in 2022.
  • Usana Health Sciences' Return on Invested Capital stood at 0.31% in 2021, then plummeted by -74bps to 0.08% in 2022, then surged by 47bps to 0.12% in 2023, then plummeted by -44bps to 0.07% in 2024, then plummeted by -57bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for USNA's Return on Invested Capital are 0.03% (Q3 2025), 0.06% (Q2 2025), and 0.05% (Q1 2025).